Darb-Esfahani et al. have shown that PD-1/PD-L1 expressions in high-grade serous ovarian cancer were significantly associated with favorable progression-free survival (PFS) and overall survival (OS) [10]. Here, PDCD1 is linked to ovarian serous adenocarcinoma.